Literature DB >> 1324055

Direct and indirect stimulations of cyclic AMP formation in human brain.

D A Kendall1, P J Millns, J L Firth.   

Abstract

1. Adenosine 3':5'-cyclic monophosphate (cyclic AMP) formation, by use of an [3H]-adenine prelabelling assay, was measured in fragments of human cerebral cortex, taken in the course of various neurosurgical procedures. 2. Large accumulations of [3H]-cyclic AMP due to isoprenaline, noradrenaline and adenosine and small effects due to forskolin were observed. Histamine, 5-hydroxytryptamine (5-HT) and the excitatory amino acids glutamate and quisqualate were ineffective. 3. The response to noradrenaline consisted of two components; a direct beta-adrenoceptor response and an enhancement mediated by an alpha-adrenoceptor which appears to be similar to that in rat cerebral cortex. 4. The response to isoprenaline was also potentiated by histamine H1 receptor stimulation but the direct effect of 2-chloroadenosine was not altered by histamine, 5-HT or quisqualate. 5. It is concluded that some, but not all, of the indirect modulations of cyclic AMP formation previously observed in experimental animal brain exist in human cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324055      PMCID: PMC1908701          DOI: 10.1111/j.1476-5381.1992.tb09075.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  H1 and H2 receptors in the histamine-induced accumulation of cyclic AMP in guinea pig brain slices.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

2.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

3.  Cyclic AMP formation in human brain: an in vitro stimulation by neurotransmitters.

Authors:  R Fumagalli; V Bernareggi; F Berti; M Trabucchi
Journal:  Life Sci I       Date:  1971-10-01

4.  The response of human cerebrum adenyl cyclase to biogenic amines.

Authors:  H Shimizu; S Tanaka; T Suzuki; Y Matsukado
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

5.  Neuropeptides modulate the beta-adrenergic response of purified astrocytes in vitro.

Authors:  G Rougon; M Noble; A W Mudge
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

6.  Activation of cyclic AMP-generating systems in brain membranes and slices by the diterpene forskolin: augmentation of receptor-mediated responses.

Authors:  J W Daly; W Padgett; K B Seamon
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

7.  Augmentation of neurotransmitter receptor-stimulated cyclic AMP accumulation in rat brain: differentiation between the effects of baclofen and phorbol esters.

Authors:  R W Scherer; E W Karbon; J W Ferkany; S J Enna
Journal:  Brain Res       Date:  1988-06-07       Impact factor: 3.252

8.  Inhibition by forskolin of excitatory amino acid-induced accumulation of cyclic AMP in guinea pig hippocampal slices.

Authors:  A Baba; Y Nishiuchi; A Uemura; T Tatsuno; H Iwata
Journal:  J Neurochem       Date:  1988-07       Impact factor: 5.372

9.  Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation.

Authors:  D A Kendall; E Brown; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1985-08-07       Impact factor: 4.432

10.  Discriminatory effects of forskolin and EGTA on the indirect cyclic AMP responses to histamine, noradrenaline, 5-hydroxytryptamine, and glutamate in guinea-pig cerebral cortical slices.

Authors:  J Donaldson; D A Kendall; S J Hill
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

View more
  1 in total

1.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.

Authors:  S P Alexander; J Cooper; J Shine; S J Hill
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.